Skip to main content
. 2025 Sep-Oct;38(5):933–939. doi: 10.3122/jabfm.2025.250039R1

Table 1.

Practice Regions of Survey Respondents and Survey Responses

Total Survey Responses: 146
Practice Region
 Southeast Minnesota 88 (61%)
 Southwest Minnesota 27 (19%)
 Northwest Wisconsin 19 (13%)
 Southwest Wisconsin 12 (8%)
Currently prescribing buprenorphine
 Yes, for OUD 19 (14%)
 Yes, for chronic pain 7 (5%)
 Yes, for both OUD & chronic pain 26 (19%)
 No 88 (63%)
Desire to prescribe buprenorphine
 Yes 101 (72%)
 No 39 (28%)
Perceived barriers
 Lack of knowledge 65 (76%)
Respondents can select multiple choices
 Lack of confidence 67 (78%)
 Lack of patient need 13 (15%)
 Time constraint 26 (30%)
 Lack of institutional support 23 (27%)
Interest in using eConsult for buprenorphine
 Yes 121 (89%)
Initiation or dose adjustment for chronic pain
 No 15 (11%)
Would an eConsult encourage you to consider
 Yes 109 (87%)
Transitioning more chronic opioid patients to buprenorphine?
 No 17 (13%)

Abbreviation: OUD, opioid use disorder.